Current through Register Vol. XLI, No. 50, December 13, 2024
Section 14-2-8 - New Drug Approval8.1. The addition of new drugs or drug indications by the Board as cited in subsection 7.2 of this rule may be based on any of the following criteria: 8.1.a. A new or existing drug has been approved by the Food and Drug Administration for the treatment of the eye or its appendages.8.1.b. A new drug or new drug indication has gained accepted use in the eye care field. Such acceptance may be indicated by its inclusion in the curriculum of an optometry school accredited by the Accreditation Council on Optometric Education or its successor approved by the U.S. Department of Education or approved post-graduate continuing education, through peer-reviewed, evidence-based research and professional journal articles, or by inclusion in established standards of practice and care published by professional organizations.